Evinova will aim to better meet the needs of healthcare professionals, regulators and patients.
The new healthtech business aims to bring to market established and scaled digital technology solutions which are already used globally by AZ, to pharmaceutical, biotechnology and contract research organisations (CROs) to support global clinical research.
Evinova will develop new medicines more efficiently and cost-effectively by optimising clinical trial design and delivery, bringing care closer to home for patients and reducing the burden on health systems.
